Modulation of the Fce Receptor I Signaling by Tyrosine Kinase Inhibitors: Search for Therapeutic Targets of Inflammatory and Allergy Diseases

By  

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1727-1737

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Rho-Kinase Inhibitors in Cardiovascular Diseases

By Hirooka Yoshitaka   Shimokawa Hiroaki  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite

Metabolism considerations for kinase inhibitors in cancer treatment

By Duckett Derek R   Cameron Michael D  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 10, 2010-10 ,pp. : 1175-1193

Informa Healthcare

Access to resources Recommend Favorite

Emerging tyrosine kinase inhibitors for esophageal cancer

By Ku Geoffrey Y   Ilson David H  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 219-230

Informa Healthcare

Access to resources Recommend Favorite

Emerging tyrosine kinase inhibitors for head and neck cancer

By Bossi Paolo   Locati Laura   Licitra Lisa  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 4, 2013-12 ,pp. : 445-459

Informa Healthcare

Access to resources Recommend Favorite